What’s the cost of finding the right fit? The cost of conducting NSP business in a range of modalities

Contemporary Drug Problems

Volumn 41, Issue 1, 2014, Pages 41-56

  Treloar, Carla ^a   McLeod, Ross ^b   Yates, Kenneth ^a   Mao, Limin ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b University of New South Wales ^*

Author keywords

Australia; Cost analysis; Health promotion; Health services management; Injecting drug use; Needle and syringe program

Indexed keywords

EID: 84942768723     PISSN: 00914509     EISSN: 21631808     Source Type: Journal    
DOI: 10.1177/009145091404100103     Document Type: Article

References (44)

1. Australian Government Department of Health and Ageing. (2010). 6th National HIV Strategy 2010-2013. Canberra: Commonwealth of Australia.
2. Bryant, J., & Hopwood, M. (2009). Secondary exchange of sterile injecting equipment in a high distribution environment: A mixed method analysis in south east Sydney, Australia. International Journal of Drug Policy, 20, 324-328.
3. Bryant, J., Paquette, D., & Wilson, H. (2012). Syringe coverage in an Australian setting: Does a high level of syringe coverage moderate syringe sharing behaviour? AIDS and Behavior, 16(5), 1156-1163. doi:DOI10.1007/s10461-011-0010-3
4. Bryant, J., Topp, L., Hopwood, M., Iversen, J., Treloar, C., & Maher, L. (2010). Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south east Sydney. Drug and Alcohol Review, 29, 364-370.
5. Bryant, J., & Treloar, C. (2006). Risk practices and other characteristics of injecting drug users who obtain injecting equipment from pharmacies and personal networks. International Journal of Drug Policy, 17, 418-424.
6. Bryant, J., Wilson, H., Hull, P., & Treloar, C. (2010). Pharmacy Needle and Syringe Survey: New South Wales 2006-2008. Sydney: National Centre in HIV Social Research, The University of New South Wales.
7. Commonwealth of Australia. (2010). Third National Hepatitis C Strategy 2010-2013. Canberra: Commonwealth of Australia.
8. Craib, K., Spitall, P., Patel, S., Christian, W., Moniruzzaman, A., Pearce, M. et al. (2009). Prevalence and incidence of hepatitis C virus infection among Aboriginal young people who use drugs: Results from the Cedar Project. Open Medicine, 3(4), e220-227.
9. Elliott, A., & Chapman, S. (2000). ‘‘Heroin hell of their own making”: Construction of heroin users in the Australian press 1992-97. Drug and Alcohol Review, 19, 191-201.
10. Hall, M., Dugan, E., Zheng, B., & Mishra, A. (2001). Trust in physicians and medical institutions: What is it, can it be measured, and does it matter? The Milbank Quarterly, 79(4), 613-639.
11. Health Outcomes International Pty Ltd, National Centre in HIV Epidemiology and Clinical Research, & Drummond, M. (2002). Return on investment in needle and syringe programs in Australia: Summary Report. Canberra: Commonwealth Department of Health and Ageing.
12. Heinzerling, K., Jral, A., Flynn, N., Anderson, R., Scott, A., Gilbert, M., et al. (2006). Unmet need for recommended preventive health services among clients of California syringe exchange programs: Implications for quality improvement. Drug and Alcohol Dependence, 81, 167-178.
13. Islam, M., Grummett, S., White, A., Reid, S., Day, C., & Haber, P. (2011). A primary healthcare clinic in a needle syringe program may contribute to HIV prevention by early detection of incident HIV in an injecting drug user. Australian and New Zealand Journal of Public Health, 35(3), 294-295.
14. Islam, M., Stern, T., Conigrave, K., & Wodak, A. (2008). Client satisfaction and risk behaviours of the users of syringe dispensing machines: A pilot study. Drug and Alcohol Review, 27(1), 13-19. doi:http://onlinelibrary.wiley.com/doi/10.1080/09595230701711199/pdf
15. Islam, M., Topp, L., Conigrave, K., White, A., Haber, P., & Day, C. (2012). Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia. International Journal of Drug Policy, 24(4)m 326-332.
16. Islam, M., Topp, L., Day, C., Dawson, A.. & Conigrave, K. M. (2012). The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature Review. International Journal of Drug Policy, 23(2), 94-102.
17. Jauffret-Roustide, M., Cohen, J., Poisot-Martin, I., Spire, B., Gossop, M., Carrieri, M., & MANIF 2000 Study Group. (2012). Distributive sharing among HIV-HCV co-infected injecting drug users: The preventive role of trust in one’s physician. AIDS Care, 24(2), 232-238.
18. Jones, L., Pickering, L., Sumnall, H., McVeigh, J., & Bellis, M. A. (2010). Optimal provisions of needle and syringe programmes for injecting drug users: A systematic review. International Journal of Drug Policy, 21, 335-342.
19. Körner, H., & Treloar, C. (2003). Needle and syringe programmes in the local media: Needle anger versus effective education in the community. International Journal of Drug Policy, 15(1), 46-55.
20. Kwon, J., Anderson, J., Kerr, C., Thein, H., Zhang, L., Iversen, J., et al. (2012). Estimating the cost-effectiveness of needle-syringe programs in Australia. AIDS, 26, 2201-2210.
21. Kwon, J., Iversen, J., Maher, L., Law, M., & Wilson, D. (2009). The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: A model-based analysis. Journal Acquired Immune Deficiency Syndrones, 51, 462-469.
22. Maher, L., Jalaludin, B., Chant, K., Jayasuriya, R., Sladden, T., Kaldor, J., et al. (2006). Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction, 101, 1499-1508.
23. Mandell, W., Kim, J., Latkin, C., & Suh, T. (1999). Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. American Journal of Drug & Alcohol Abuse, 25(1), 117-127.
24. Masson, C., Sorensen, J. L., Perlman, D., Shopshire, M., Delucchi, K., Chen, T., et al. (2007). Hospital-versus community-based syringe exchange: A randomized controlled trial. AIDS Education & Prevention, 19(2), 97-110.
25. Moore, D., & Dietze, P. (2005). Enabling environments and the reduction of drug-related harm: Re-framing Australian policy and practice. Drug & Alcohol Review, 24, 275-284.
26. Moore, D., & Fraser, S. (2006). Putting at risk what we know: Reflecting on the drug-using subject in harm reduction and its political implications. Social Science & Medicine, 62(12), 3035-3047.
27. National Centre for HIV Epidemiology and Clinical Research. (2009). Return on investment 2: Evaluating the cost-effectiveness of needle and syringe programs in Australia 2009. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales.
28. NSW Ministry of Health. (2013). NSW Needle and Syringe Program: Guidelines. Sydney: NSW Ministry of Health.
29. Ostertag, S., Wright, B., Broadhead, R., & Altice, F. (2006). Trust and other characteristics associated with health care utilization by injection drug users. The Journal of Drug Issues, 36(4), 935-974.
30. Pilowsky, D., Li-Tzy Wu, L.-T., Burchett, B., Blazer, D., & Ling, W. (2011). Depressive symptoms, substance use and HIV-related high risk behaviors among opioid-dependent individuals: Results from the Clinical Trials Network. Substance Use & Misuse, 46(14), 1716-1725.
31. Rhodes, T. (2009). Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy, 20(3), 193-201.
32. Rhodes, T., & Quirk, A. (1998). Drug users’ sexual relationships and the social organisation of risk: The sexual relationship as a site of risk management. Social Science & Medicine, 46, 157-169.
33. Rhodes, T., Singer, M., Bourgois, P., Friedman, S., & Strathdee, S. (2005). The social structural production of HIV risk among injecting drug users. Social Science and Medicine, 61, 1026-1044.
34. Sarang, A., Rhodes, T., Sheon, N., & Page, K. (2010). Policing drug users in Russia; Risk, fear and structural violence. Substance Use & Misuse, 56, 813-864.
35. Seear, K., Gray, R., Fraser, S., Treloar, C., Bryant, J., & Brener, L. (2012). Rethinking safety and fidelity: The role of love and intimacy in hepatitis C transmission and prevention. Health Sociology Review, 21(3), 272-286.
36. Strathdee, S., Patrick, D., Archibald, C., & Ofner, M. (1997). Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction, 92, 1339-1347.
37. Thein, H., Denoe, M., van Beek, I., Dore, G., & MacDonald, M. (2003). Injecting behaviour of injecting drug users at needle and syringe programmes and pharmacies in Australia. International Journal of Drug Policy, 14, 425-430.
38. Thiede, M. (2005). Information and access to health care: Is there a role for trust? Social Science & Medicine, 61, 1452-1462. doi:10.1016/j.socscimed.2004.11.076
39. Thorpe, L. E., Ouellet, L. J., Hershow, R., Bailey, S. L., Williams, I. T., Williamson, J., et al (2002). Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology, 155, 645-653.
40. Treloar, C., & Cao, W. (2005). Barriers to use of Needle and Syringe Programmes in a high drug use area of Sydney, New South Wales. International Journal of Drug Policy, 16, 308-315.
41. van Beek, I. (2007). Case study: Accessible primary health care—A foundation to improve health outcomes for people who inject drugs. International Journal of Drug Policy, 18(4), 329-332.
42. Wand, H., Spiegelman, D., Law, M., Jalaludin, B., Kaldor, J., & Maher, L. (2009). Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: Implications for prevention policy and planning. Addiction, 104(12), 2049-2056.
43. World Health Organization. (2012). Guidance on Prevention of Viral Hepatitis B and C Among People Who Inject Drugs. Geneva: World Health Organization.
44. World Health Organization (WHO), United Nations Office on Drugs and Crime (UNODC), & Joint United Nations Programme on HIV/AIDS (UNAIDS). (2009). Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: World Health Organization.